Hi Pazy
u can try not sure and nobody is)
my guess ?
all funds have highly qualified team. They know very well the segment they are in. If the broker is bio tech they have really qualified experts working.
they work with risk management and they dont “ gamble” they invest in x percentage of risks.
when a company like MSB lose in that sequence 100% of all endpoint means clear pattern “ we dont have the treatment”
what creates more problem is the secondary that most if cases was positive.
and to make more complicate we have one deal with a major Pharma.
if they say.... yes its a good trial... we go to roof... if they say... uhmmm leave to another time ... we go to hell.
we have no income , no perspective in short term to have and as much people try squeeze the evidences . The only one really present is
we are in trouble...
the fact we raise capital so recently (-again) is not just a dilution if value if the share, but invite us to think, after 10 years are we doing good ?
can we go ahead with more trials now addressing this secondary point ? Have people available if Novartis say no ?
Funds are cruel.
too much risk to bear even if the chances are good.
they cant cope with share goes to 1 !!!
they meed to explain to governance how they expose the funds if thousands of investors.
i think the seduction , they dream , the confidence all gone.
share when no buyers comes everyday, u can bet. sellers comes.
CATO
note- just my view
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2021 - paradigm shift
MSB Trading 2021 - paradigm shift, page-4901
-
- There are more pages in this discussion • 5,310 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10033 | 1.485 |
4 | 53700 | 1.480 |
1 | 770 | 1.475 |
3 | 62048 | 1.460 |
1 | 50000 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 21995 | 1 |
1.505 | 24000 | 1 |
1.510 | 13666 | 2 |
1.515 | 99798 | 1 |
1.520 | 27250 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
MSB (ASX) Chart |